Literature DB >> 12828935

Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy.

Bin Liu1, Arthur H Neufeld.   

Abstract

Glaucoma is an optic neuropathy that is associated with elevated intraocular pressure in most patients. We have previously demonstrated that the mechanism by which pressure damages optic nerve axons involves excessive nitric oxide generated by inducible nitric oxide synthase (NOS-2). We have now found that activation of the epidermal growth factor receptor (EGFR) induces NOS-2 in astrocytes of the human optic nerve head (ONH) in vitro and EGFR is significantly upregulated and tyrosine phosphorylated in reactive astrocytes in human glaucomatous ONHs in vivo. Furthermore, in response to elevated hydrostatic pressure, EGFR rapidly becomes phosphorylated in the nucleus. This pressure-dependent activation of EGFR is necessary for NOS-2 induction. Our results suggest that activation and nuclear localization of EGFR may be needed for induction of NOS-2 in response to elevated intraocular pressure in glaucomatous optic neuropathy. Identification of this key signaling pathway provides new therapeutic approaches to pharmacological neuroprotection for glaucoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828935     DOI: 10.1016/s0969-9961(03)00010-x

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.

Authors:  Jeffrey M Harder; Catherine E Braine; Pete A Williams; Xianjun Zhu; Katharine H MacNicoll; Gregory L Sousa; Rebecca A Buchanan; Richard S Smith; Richard T Libby; Gareth R Howell; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-26       Impact factor: 11.205

2.  EGFR regulates macrophage activation and function in bacterial infection.

Authors:  Dana M Hardbower; Kshipra Singh; Mohammad Asim; Thomas G Verriere; Danyvid Olivares-Villagómez; Daniel P Barry; Margaret M Allaman; M Kay Washington; Richard M Peek; M Blanca Piazuelo; Keith T Wilson
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

3.  Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.

Authors:  Yukihiro Shiga; Masato Akiyama; Koji M Nishiguchi; Kota Sato; Nobuhiro Shimozawa; Atsushi Takahashi; Yukihide Momozawa; Makoto Hirata; Koichi Matsuda; Taiki Yamaji; Motoki Iwasaki; Shoichiro Tsugane; Isao Oze; Haruo Mikami; Mariko Naito; Kenji Wakai; Munemitsu Yoshikawa; Masahiro Miyake; Kenji Yamashiro; Kenji Kashiwagi; Takeshi Iwata; Fumihiko Mabuchi; Mitsuko Takamoto; Mineo Ozaki; Kazuhide Kawase; Makoto Aihara; Makoto Araie; Tetsuya Yamamoto; Yoshiaki Kiuchi; Makoto Nakamura; Yasuhiro Ikeda; Koh-Hei Sonoda; Tatsuro Ishibashi; Koji Nitta; Aiko Iwase; Shiroaki Shirato; Yoshitaka Oka; Mamoru Satoh; Makoto Sasaki; Nobuo Fuse; Yoichi Suzuki; Ching-Yu Cheng; Chiea Chuen Khor; Mani Baskaran; Shamira Perera; Tin Aung; Eranga N Vithana; Jessica N Cooke Bailey; Jae H Kang; Louis R Pasquale; Jonathan L Haines; Janey L Wiggs; Kathryn P Burdon; Puya Gharahkhani; Alex W Hewitt; David A Mackey; Stuart MacGregor; Jamie E Craig; R Rand Allingham; Micheal Hauser; Adeyinka Ashaye; Donald L Budenz; Stephan Akafo; Susan E I Williams; Yoichiro Kamatani; Toru Nakazawa; Michiaki Kubo
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

Review 4.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098

5.  Pressure activates epidermal growth factor receptor leading to the induction of iNOS via NFkappaB and STAT3 in human proximal tubule cells.

Authors:  Nalini V Broadbelt; Jie Chen; Randi B Silver; Dix P Poppas; Diane Felsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

6.  Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.

Authors:  Matthias Erschbamer; Karin Pernold; Lars Olson
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

7.  NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.

Authors:  Karuppaiyah Selvendiran; Anna Bratasz; Liyue Tong; Louis J Ignarro; Periannan Kuppusamy
Journal:  Cell Cycle       Date:  2007-09-28       Impact factor: 4.534

Review 8.  Friend or foe? Resolving the impact of glial responses in glaucoma.

Authors:  Elaine C Johnson; John C Morrison
Journal:  J Glaucoma       Date:  2009 Jun-Jul       Impact factor: 2.503

9.  Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts.

Authors:  Humaira Ayub; Muhammad Imran Khan; Shazia Micheal; Farah Akhtar; Muhammad Ajmal; Sobia Shafique; Syeda Hafiza Benish Ali; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2010-01-11       Impact factor: 2.367

Review 10.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.